PortfoliosLab logoPortfoliosLab logo
IHI vs. XBI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IHI vs. XBI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares U.S. Medical Devices ETF (IHI) and SPDR S&P Biotech ETF (XBI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IHI achieves a -19.70% return, which is significantly lower than XBI's 9.42% return. Both investments have delivered pretty close results over the past 10 years, with IHI having a 8.86% annualized return and XBI not far behind at 8.53%.


IHI

1D
2.76%
1M
0.16%
YTD
-19.70%
6M
-21.09%
1Y
-19.03%
3Y*
-2.23%
5Y*
-1.96%
10Y*
8.86%

XBI

1D
2.77%
1M
-0.28%
YTD
9.42%
6M
8.61%
1Y
62.35%
3Y*
15.65%
5Y*
1.14%
10Y*
8.53%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IHI vs. XBI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IHI
iShares U.S. Medical Devices ETF
-19.70%6.88%8.62%3.24%-19.80%21.03%24.17%32.75%15.45%30.81%
XBI
SPDR S&P Biotech ETF
9.42%35.89%1.01%7.60%-25.87%-20.45%48.33%32.56%-15.28%43.77%

Correlation

The correlation between IHI and XBI is 0.38, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.38

Correlation (3Y)
Calculated over the trailing 3-year period

0.45

Correlation (5Y)
Calculated over the trailing 5-year period

0.52

Correlation (10Y)
Calculated over the trailing 10-year period

0.56

Correlation (All Time)
Calculated using the full available price history since May 8, 2006

0.62

Over the past year, the correlation between IHI and XBI has dropped to 0.38 - well below their long-term average of 0.62, suggesting their price drivers have been diverging.

IHI vs. XBI - Sectors Allocation Comparison


Sectors
IHI
XBI

Healthcare

100.0%
99.8%

Industrials

0.2%

-

Basic Materials

-

0.2%

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

0.2%

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

IHI
100.0%
XBI
99.8%

Industrials

IHI
0.2%
XBI

-

Basic Materials

IHI

-

XBI
0.2%

Communication Services

IHI

-

XBI

-

Consumer Cyclical

IHI

-

XBI

-

Consumer Defensive

IHI

-

XBI

-

Energy

IHI

-

XBI

-

Financial Services

IHI

-

XBI
0.2%

Real Estate

IHI

-

XBI

-

Technology

IHI

-

XBI

-

Utilities

IHI

-

XBI

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IHI vs. XBI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IHI
IHI Risk / Return Rank: 11
Overall Rank
IHI Sharpe Ratio Rank: 11
Sharpe Ratio Rank
IHI Sortino Ratio Rank: 11
Sortino Ratio Rank
IHI Omega Ratio Rank: 22
Omega Ratio Rank
IHI Calmar Ratio Rank: 33
Calmar Ratio Rank
IHI Martin Ratio Rank: 00
Martin Ratio Rank

XBI
XBI Risk / Return Rank: 8080
Overall Rank
XBI Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
XBI Sortino Ratio Rank: 7575
Sortino Ratio Rank
XBI Omega Ratio Rank: 6767
Omega Ratio Rank
XBI Calmar Ratio Rank: 9393
Calmar Ratio Rank
XBI Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IHI vs. XBI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Medical Devices ETF (IHI) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IHIXBIDifference
Sharpe ratioReturn per unit of total volatility

-3.57

Sortino ratioReturn per unit of downside risk

-4.89

Omega ratioGain probability vs. loss probability

0.83

1.40

-0.57

Calmar ratioReturn relative to maximum drawdown

-0.73

6.45

-7.18

Martin ratioReturn relative to average drawdown

-1.85

19.53

-21.39

IHI vs. XBI - Sharpe Ratio Comparison

The current IHI Sharpe Ratio is -1.13, which is lower than the XBI Sharpe Ratio of 2.45. The chart below compares the historical Sharpe Ratios of IHI and XBI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IHIXBIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-1.13

2.45

-3.57

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.10

0.04

-0.14

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.45

0.27

+0.18

Sharpe Ratio (All Time)

Calculated using the full available price history

0.47

0.36

+0.11

Drawdowns

IHI vs. XBI - Drawdown Comparison

The maximum IHI drawdown since its inception was -49.65%, smaller than the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for IHI and XBI.


Loading charts...

Drawdown Indicators


IHIXBIDifference

Max Drawdown

Largest peak-to-trough decline

-49.65%

-63.89%

+14.24%

Max Drawdown (1Y)

Largest decline over 1 year

-26.11%

-9.72%

-16.39%

Max Drawdown (3Y)

Largest decline over 3 years

-26.64%

-32.99%

+6.35%

Max Drawdown (5Y)

Largest decline over 5 years

-33.12%

-54.71%

+21.59%

Max Drawdown (10Y)

Largest decline over 10 years

-33.25%

-63.89%

+30.64%

Current Drawdown

Current decline from peak

-24.17%

-22.89%

-1.28%

Average Drawdown

Average peak-to-trough decline

-8.32%

-20.93%

+12.61%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.29%

3.20%

+7.09%

Volatility

IHI vs. XBI - Volatility Comparison

The current volatility for iShares U.S. Medical Devices ETF (IHI) is 7.01%, while SPDR S&P Biotech ETF (XBI) has a volatility of 9.69%. This indicates that IHI experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IHIXBIDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.01%

9.69%

-2.68%

Volatility (6M)

Calculated over the trailing 6-month period

13.05%

20.31%

-7.26%

Volatility (1Y)

Calculated over the trailing 1-year period

16.96%

25.60%

-8.64%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.99%

32.20%

-13.21%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.79%

32.00%

-12.21%

IHI vs. XBI - Expense Ratio Comparison

IHI has a 0.43% expense ratio, which is higher than XBI's 0.35% expense ratio.


Dividends

IHI vs. XBI - Dividend Comparison

IHI's dividend yield for the trailing twelve months is around 0.45%, more than XBI's 0.33% yield.


PositionTTM20252024202320222021202020192018201720162015
IHI
iShares U.S. Medical Devices ETF
0.45%0.34%0.46%0.53%0.45%0.25%0.25%0.33%0.26%0.37%0.55%1.28%
XBI
SPDR S&P Biotech ETF
0.33%0.37%0.15%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%

Frequently Asked Questions


IHI and XBI have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XBI has higher volatility (9.69%) compared to IHI (7.01%). In terms of maximum drawdown, IHI dropped -49.65% vs XBI's -63.89%.

On 10-year performance, IHI leads with 8.86% vs 8.53% for XBI. On fees, XBI is cheaper at 0.35% per year. On volatility, IHI has been the lower-risk option at 7.01%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, IHI has performed better with a 8.86% return vs 8.53%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

XBI is cheaper with a 0.35% expense ratio, compared with 0.43% for IHI.

IHI has the higher dividend yield at 0.45%, compared with 0.33% for XBI.

IHI tracks Dow Jones U.S. Select Medical Equipment Index, while XBI tracks S&P Biotechnology Select Industry Index. They also come from different issuers: iShares and State Street. Their fees differ too: 0.43% for IHI and 0.35% for XBI.

XBI currently has the higher Sharpe Ratio (2.45 vs -1.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IHI and XBI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer